beta-naphthylalanine and Disease-Models--Animal

An imaging method capable of using a signal from pancreatic beta cells to determine their mass would be of immense value in monitoring the progression of diabetes as well as response to treatment. Somatostatin receptors (SSTRs) are expressed on beta cells and are a potential target for imaging. The main objective of this study was to investigate whether pancreatic beta cells are a target for radiolabeled naphthylalanine derivatives. The molecules were subjected to in vitro and ex vivo evaluations. Pancreatic uptake of radioactivity was lower in nonobese diabetic (NOD) mice than normal mice at all time points investigated (P < .05) and correlated with the number of islets in tissue sections of both control and NOD mice. Immunohistochemical and confocal fluorescent microscopic studies showed colocalization of insulin and the conjugate radioligand in the pancreas. The results demonstrated that pancreatic uptake is receptor-mediated, and that beta cells are the primary target.

Topics: Animals; Autoradiography; beta-Alanine; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Immunohistochemistry; Insulin; Insulin-Secreting Cells; Iodine Radioisotopes; Kinetics; Mice; Mice, Inbred CBA; Mice, Inbred NOD; Microscopy, Confocal; Radioligand Assay; Receptors, Somatostatin; Somatostatin; Staining and Labeling; Tissue Culture Techniques; Transfection